tiprankstipranks
Trending News
More News >
Abbisko Cayman Limited (HK:2256)
:2256
Hong Kong Market
Advertisement

Abbisko Cayman Limited (2256) Similar Stocks

Compare
7 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Abbisko Cayman Limited
HK$14.56
HK$10.45B
54.91
237.82%
8 Buy
0 Hold
0 Sell
Strong Buy
Alphamab Oncology
HK$11.50
HK$11.53B
45.14
213.35%
0 Buy
0 Hold
0 Sell
Hold
Ascletis Pharma, Inc.
HK$9.65
HK$9.11B
-32.00
584.40%
3 Buy
1 Hold
0 Sell
Strong Buy
HBM Holdings Ltd.
HK$13.47
HK$11.43B
17.53
995.12%
2 Buy
0 Hold
0 Sell
Moderate Buy
CStone Pharmaceuticals
HK$6.26
HK$9.18B
-20.28
191.16%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$10.46
HK$7.11B
184.79
13.20%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2256
Abbisko Cayman Limited
14.56
10.20
233.94%
HK:9966
Alphamab Oncology
11.50
7.63
197.16%
HK:1672
Ascletis Pharma, Inc.
9.65
8.21
570.14%
HK:2142
HBM Holdings Ltd.
13.47
12.27
1022.50%
HK:2616
CStone Pharmaceuticals
6.26
4.21
205.37%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
10.46
1.28
13.94%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis